CDKN2A and neoplasm: Cyclin-dependent kinase inhibitor 2A (CDKN2A; 9p21.3) encodes p16INK4A and p14ARF, which are vital regulators of the cell cycle and play a significant role in programmed cell death through their tumor-suppressive activities [23, 24].